Andrew Komjathy

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Andrew Komjathy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Komjathy:

Company Role Class Num Shares Value Price $ Report Date Ownership
Astria Therapeutics, Inc. Chief Commercial Officer Common Stock 0 $0 $13.09 23 Jan 2026 Direct
Astria Therapeutics, Inc. Chief Commercial Officer Common Stock 0 $0 $13.09 23 Jan 2026 Indirect
Astria Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 0 23 Jan 2026 Direct

Insider Reports Filed by Andrew Komjathy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATXS Astria Therapeutics, Inc. 23 Jan 2026 5 $0 4 Chief Commercial Officer 23 Jan 2026, 16:29
ATXS Astria Therapeutics, Inc. 21 Mar 2025 1 $0 4 Chief Commercial Officer 25 Mar 2025, 16:06
ATXS Astria Therapeutics, Inc. 08 Feb 2024 1 $0 4 Chief Commercial Officer 12 Feb 2024, 16:05
ATXS Astria Therapeutics, Inc. 02 Jun 2023 1 $0 4 Chief Commercial Officer 06 Jun 2023, 08:07
ATXS Astria Therapeutics, Inc. 01 Mar 2022 1 $0 4 Chief Commercial Officer 03 Mar 2022, 18:17
ATXS Astria Therapeutics, Inc. 28 Dec 2021 2 $0 5 Chief Commercial Officer 10 Feb 2022, 15:08
ATXS Astria Therapeutics, Inc. 19 Nov 2021 1 +$670 4 Chief Commercial Officer 23 Nov 2021, 15:12
ATXS CATABASIS PHARMACEUTICALS INC 02 Jun 2021 1 $0 4 Chief Commercial Officer 02 Jun 2021, 19:19